Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 6;9(1):87.
doi: 10.3390/jof9010087.

An Immunomodulatory Polysaccharide-Protein Complex Isolated from the Polypore Fungus Royoporus badius

Affiliations

An Immunomodulatory Polysaccharide-Protein Complex Isolated from the Polypore Fungus Royoporus badius

Bryan C C Lim et al. J Fungi (Basel). .

Abstract

Many wild edible polypore mushrooms have medicinal value. In this study, we investigate the potential medicinal properties of the wild polypore mushroom Royoporus badius collected from north-central British Columbia, Canada. Water extract from R. badius was found to exhibit potent immunomodulatory activity. The extract was purified using DEAE-Sephadex anion-exchange chromatography as well as Sephacryl S-500 and HPLC BioSEC5 size-exclusion chromatography, to yield a novel polysaccharide-protein complex (IMPP-Rb).IMPP-Rb has a peak maxima molecular weight (Mp) of 950 kDa. GC-MS analyses showed that IMPP-Rb is composed predominantly of glucose (49.2%), galactose (11.3%), mannose (10.8%), rhamnose (9.6%), and galacturonic acid (8.2%), with smaller amounts of xylose (5.2%), fucose (2.8%), N-acetyl glucosamine (1.8%), and arabinose (1.2%). IMPP-Rb has multiple linkages, with 4-Glcp, 4-Manp, 6-Manp, 3,4-Manp, 4-Xylp, and 2-Rhap being the most prominent. IMPP-Rb is capable of inducing many cytokines in vitro and the protein component is indispensable for its immunomodulatory activity. IMPP-Rb has potential application as an immuno-stimulatory agent with pharmaceutical value.

Keywords: Picipes badius; Polyporus badius; Royoporus badius; immunomodulation; polysaccharide–protein.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Immunomodulatory and antiproliferative activities of crude extracts obtained from R. badius. (a) Dose- and (b) time-dependent MTT cell viability assays on HeLa cells. The concentration used for the time-dependent experiment was (b) 0.5 mg/mL. At 1 mg/mL, crude extracts from specimens (c) CL86 and (d) CL152 were assessed for their ability to induce TNF-α production in RAW264.7 macrophage cells, as an indicator of immunomodulation. Lipopolysaccharide (LPS) was used as a positive control, while media, water, and methanol were used as negative controls. Results presented are representations of two separate experiments (n = 2). Error bars show SD. One-way ANOVA (Tukey test) was used for statistical analysis. * p < 0.05 compared with the water control.
Figure 2
Figure 2
Purification of IMPP-Rb from R. badius. (a) Summary of the purification scheme used. (b) Purification using DEAE-Sephadex (column 2). Flow-through and eluent (post- 1 M NaCl) from a 750 mL DEAE column were pooled, dialyzed, and lyophilized. Various concentrations of samples were assessed for immunomodulatory activity, as indicated. Results shown are representative of two separate experiments.
Figure 3
Figure 3
Purification of IMPP-Rb from R. badius using Sephacryl S-500 (column 3). Collected fractions were assessed for their ability to induce TNF-α production in RAW264.7 cells. TNF-α levels plotted against (a) carbohydrate contents, and (b) protein contents. Results are representative of three separate experiments.
Figure 4
Figure 4
Purification of IMPP-Rb from R. badius using HPLC BioSEC5 (column 4). (a) Pooled, dialyzed, and lyophilized bioactive fractions from Sephacryl S-500 (column 3) were injected into BioSEC5. (b) Peak 1 (6–7.5 min) purified from (a) was reassessed for purity using BioSEC5. (c) Peak 2 (11–11.6 min) purified from (a) was reassessed for purity using BioSEC5. The top panel shows the refractive index spectrum and bottom panel indicates the UV spectrum at 280 nm.
Figure 5
Figure 5
FTIR spectrum of IMPP-Rb.
Figure 6
Figure 6
Effect of proteinase-K on immunomodulatory activity of polysaccharides. (a) PS-K (0.2 mg/mL) and (b) IMPP-Rb (1.5 mg/mL) were treated with 1 mg/mL proteinase-K. Samples were then heated at 80 °C for 20 min before being added to RAW264.7 cells. Results shown are mean ± SD from three independent experiments. One-way ANOVA (Tukey test) was used for statistical analysis. ns = not significant. * p < 0.05.

Similar articles

References

    1. Wasser S.P. Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. Biomed. J. 2014;37:345–356. doi: 10.4103/2319-4170.138318. - DOI - PubMed
    1. Smith A., Javed S., Barad A., Myhre V., Li W.M., Reimer K., Massicotte H.B., Tackaberry L.E., Payne G.W., Egger K.N., et al. Growth-inhibitory and immuno-modulatory activities of fungi from north central British Columbia. Int. J. Med. Mushrooms. 2017;19:485–497. doi: 10.1615/IntJMedMushrooms.v19.i6.10. - DOI - PubMed
    1. Deo G., Khatra J., Buttar S., Li W.M., Tackaberry L.E., Massicotte H.B., Egger K.N., Reimer K., Lee C.H. Anti-proliferative, immuno-stimulatory and anti-inflammatory activities of extracts derived from mushrooms collected in Haida Gwaii, British Columbia, Canada. Int. J. Med. Mushrooms. 2019;21:629–643. doi: 10.1615/IntJMedMushrooms.2019031193. - DOI - PubMed
    1. Zeb M., Lee C.H. Medicinal properties and bioactive compounds from wild mushrooms native to North America. Molecules. 2021;26:251. doi: 10.3390/molecules26020251. - DOI - PMC - PubMed
    1. Jeitler M., Michalsen A., Frings D., Hubner M., Fischer M., Koppold-Liebscher D.A., Murthy V., Kessler C.S. Significance of medicinal mushrooms in integrative oncology: A narrative review. Front. Pharmacol. 2020;11:580656. doi: 10.3389/fphar.2020.580656. - DOI - PMC - PubMed

LinkOut - more resources